Indiva Limited (NDVAF) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Indiva Limited (NDVAF) trades at $0.0223 with AI Score 42/100 (Grade C). Indiva Limited is a Canadian cannabis company focused on producing and selling a variety of cannabis products. Market cap: $4.60M, Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for NDVAF: NDVAF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NDVAF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
NDVAF: 2/3 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Indiva Limited (NDVAF) Healthcare & Pipeline Overview
Indiva Limited, based in Canada, produces and distributes cannabis products, including pre-rolls, flower, edibles, and extracts, under the INDIVA and Artisan Batch brands. The company leverages strategic partnerships to offer a diverse product portfolio and expand its market reach within the Canadian cannabis sector.
What Is the Investment Thesis for NDVAF?
Indiva Limited operates in the evolving Canadian cannabis market, presenting both opportunities and risks for investors. The company's strategy of partnering with established brands to offer a diverse product portfolio could drive revenue growth. However, Indiva's negative profit margin of -13.1% indicates challenges in achieving profitability. The company's beta of 0.58 suggests lower volatility compared to the overall market. Key catalysts include the potential for increased cannabis consumption in Canada and the successful integration of new product lines through partnerships. Investors should closely monitor Indiva's ability to improve its financial performance and navigate the competitive landscape. The company's market capitalization is $0.00B, reflecting its current valuation in the market.
Based on FMP financials and quantitative analysis
NDVAF Key Highlights
Indiva Limited operates in the Canadian cannabis market, focusing on production, processing, and sales.
- The company offers a range of products including pre-rolls, flower, edibles, and extracts under the INDIVA and Artisan Batch brands.
- Indiva partners with established brands to distribute products like Bhang Chocolate, Wana Sour Gummies, and Dime Industries vape products.
- The company's profit margin is -13.1%, indicating ongoing challenges with profitability.
- Indiva's gross margin is 28.0%, reflecting the difference between revenue and cost of goods sold.
Who Are NDVAF's Competitors?
NDVAF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| INNPF INNOCAN PHARMA Corp | $1.60 | -8.05% | $7.20M | 61 |
| GENH Generation Hemp, Inc. | $0.22 | +0.00% | $25.3M | 63 |
| GBLP Global Pharmatech, Inc. | $0.08 | +0.00% | $33.3M | 62 |
| ETST Earth Science Tech, Inc. | $0.12 | +14.45% | $35.3M | 61 |
| GDNSF Goodness Growth Holdings, Inc. | $0.45 | +0.00% | $61.1M | 64 |
| MNNGF Baijin Life Science Holdings Limited | $0.08 | +0.00% | $74.6M | 63 |
| SHIEF Shield Therapeutics plc | $0.07 | +0.00% | $75.3M | 62 |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109M | 66 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NDVAF's Key Strengths?
Diverse product portfolio through partnerships.
- Established brands (INDIVA, Artisan Batch).
- Production and manufacturing capabilities.
- Strategic partnerships with established brands.
What Are NDVAF's Weaknesses?
Negative profit margin.
- Reliance on partnerships.
- Limited geographic reach (primarily Canada).
- Small market capitalization.
What Could Drive NDVAF Stock Higher?
Expansion of product offerings through strategic partnerships.
- Increasing consumer demand for cannabis edibles and extracts in Canada.
- Potential regulatory changes in the Canadian cannabis market.
- Growth in the global cannabis market.
What Are the Key Risks for NDVAF?
Financial-distress signal — its Altman Z-Score of -2.02 sits in the distress zone (elevated bankruptcy risk).
- Intense competition in the Canadian cannabis market.
- Fluctuations in cannabis prices.
- Supply chain disruptions.
- Negative profit margin.
- Evolving regulations impacting operations.
What Are the Growth Opportunities for NDVAF?
- Expansion of Edibles and Extracts Market: The Canadian cannabis edibles and extracts market is experiencing significant growth, driven by increasing consumer demand for alternative consumption methods. Indiva's partnerships with brands like Wana Sour Gummies and Bhang Chocolate position it to capitalize on this trend. By expanding its offerings and distribution network in this segment, Indiva can increase its revenue and market share. The market for cannabis edibles and extracts is projected to reach $500 million by 2028, providing a substantial growth opportunity for Indiva.
- Strategic Partnerships and Licensing Agreements: Indiva's strategy of forming strategic partnerships and licensing agreements with established brands has proven successful in expanding its product portfolio and market reach. By continuing to pursue these partnerships, Indiva can introduce new and innovative products to the Canadian market, attracting new customers and driving revenue growth. The company's existing partnerships with brands like Dime Industries and Grön demonstrate the potential for this strategy to generate significant value.
- Increased Focus on International Markets: As the global cannabis market continues to expand, Indiva has the opportunity to explore international markets and establish a presence in new regions. By exporting its products or forming partnerships with international companies, Indiva can diversify its revenue streams and reduce its reliance on the Canadian market. The global cannabis market is projected to reach $50 billion by 2027, presenting a significant growth opportunity for Indiva.
- Development of Innovative Cannabis Products: Indiva can drive growth by investing in research and development to create innovative cannabis products that meet the evolving needs of consumers. This could include developing new formulations, delivery methods, or product categories. By differentiating itself through innovation, Indiva can attract new customers and build brand loyalty. The company's focus on quality and innovation positions it well to succeed in this area.
- Expansion of Distribution Network: Indiva can expand its distribution network by partnering with additional retailers and distributors across Canada. This would increase the availability of its products to consumers and drive revenue growth. The company can also explore direct-to-consumer sales channels, such as online ordering and delivery, to reach a wider audience. A broader distribution network will be crucial for capturing a larger share of the Canadian cannabis market.
What Are NDVAF's Competitive Advantages?
- Strategic partnerships with established brands.
- Diverse product portfolio.
- Production and manufacturing capabilities.
- Established presence in the Canadian market.
What Does NDVAF Do?
Indiva Limited, headquartered in Ottawa, Canada, is a cannabis company engaged in the production, processing, and sale of cannabis and cannabis-related products. The company offers a diverse range of products, including pre-rolls, flower, capsules, and edible and extract products, marketed under the INDIVA and Artisan Batch brands. Indiva also provides production and manufacturing services to other entities in the cannabis industry. Since its inception, Indiva has focused on building a strong presence in the Canadian cannabis market. The company has strategically partnered with established brands to expand its product offerings and distribution network. These partnerships include licensing agreements to produce and distribute Bhang Chocolate, Wana Sour Gummies, Slow Ride Bakery Cookies, Jewels Chewable Tablets, Ruby Cannabis Sugar, Grön edibles, and Dime Industries vape products. This approach allows Indiva to offer a wide variety of products to consumers while leveraging the brand recognition and market presence of its partners. Indiva's operations are primarily based in Canada, where it cultivates, processes, and distributes its products. The company's focus on quality and innovation has enabled it to establish a foothold in the competitive Canadian cannabis market. By offering a diverse product portfolio and leveraging strategic partnerships, Indiva aims to capture a significant share of the growing cannabis market in Canada.
What Products and Services Does NDVAF Offer?
- Produces and sells cannabis products in Canada.
- Offers pre-rolls, flower, capsules, and edibles.
- Provides production and manufacturing services to other cannabis companies.
- Distributes Bhang Chocolate and Wana Sour Gummies through licensing agreements.
- Markets products under the INDIVA and Artisan Batch brands.
- Partners with other companies to expand product offerings.
How Does NDVAF Make Money?
- Cultivates and processes cannabis.
- Manufactures and distributes cannabis products.
- Generates revenue through sales of its own branded products.
- Earns revenue through licensing agreements and partnerships.
What Industry Does NDVAF Operate In?
Indiva Limited operates within the rapidly evolving Canadian cannabis industry. The market is characterized by increasing consumer demand, regulatory changes, and intense competition. Companies like Indiva are striving to differentiate themselves through product innovation, strategic partnerships, and efficient operations. The industry is also subject to evolving regulations regarding production, distribution, and marketing, which can impact companies' strategies and financial performance. Competitors such as ACRDF, ACRHF, CHNC, DOGP, and GHSI are vying for market share in this dynamic landscape.
Who Are NDVAF's Key Customers?
- Adult consumers in Canada.
- Retail cannabis stores.
- Other cannabis companies seeking production services.
Key Financial Metrics
Return on assets is -13.0%, showing how much profit it generates from its asset base. Its free cash flow yield is -11.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.72 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -91.9%, the inverse of the P/E and a quick read on earnings relative to price.
Indiva Limited (NDVAF) Valuation Context
Valued at $4.60M, NDVAF is classified as a micro-cap stock. Relative to its peer group, NDVAF's quantitative score of 42/100 is below the peer average of 62/100.
Company Profile
Indiva Limited operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Ottawa, CA. The company is led by CEO Carmine Marotta. NDVAF has traded publicly since 2006.
Financial Health
Indiva Limited's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -2.02 places it in the distress zone, a signal of elevated financial risk.
NDVAF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Diverse product portfolio through partnerships.
- Established brands (INDIVA, Artisan Batch).
- Production and manufacturing capabilities.
- Strategic partnerships with established brands.
Bear Case
- Negative profit margin.
- Reliance on partnerships.
- Limited geographic reach (primarily Canada).
- Small market capitalization.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
NDVAF Latest News
No recent news available for NDVAF.
NDVAF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NDVAF.
Price Targets
Wall Street price target analysis for NDVAF.
NDVAF MoonshotScore
What does this score mean?
The MoonshotScore rates NDVAF 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Carmine Marotta
CEO
Carmine Marotta is the CEO of Indiva Limited. Information regarding his detailed background, career history, education, and previous roles is not available in the provided data. His leadership is crucial for guiding Indiva through the competitive Canadian cannabis market and executing its growth strategy.
Track Record: Information regarding Carmine Marotta's specific achievements, strategic decisions, and company milestones during his tenure as CEO is not available in the provided data. However, as CEO, he is responsible for overseeing the company's operations, financial performance, and strategic direction.
NDVAF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Indiva Limited may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries a higher degree of risk due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Limited financial disclosure.
- Potential for illiquidity.
- Lack of regulatory oversight.
- Higher risk of fraud or manipulation.
- Limited access to company information.
- Verify the company's financial statements.
- Research the company's management team.
- Assess the company's business model and competitive landscape.
- Check for any regulatory filings or legal issues.
- Evaluate the company's liquidity and trading volume.
- Consult with a financial advisor.
- Understand the risks associated with OTC investments.
- Established presence in the Canadian cannabis market.
- Partnerships with recognized brands.
- Production and manufacturing capabilities.
- Operation in a regulated industry.
What Investors Ask About Indiva Limited (NDVAF) — Healthcare
What does the AI Score mean for NDVAF?
NDVAF holds an AI Score of 42/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Indiva Limited is a Canadian cannabis company focused on producing and selling a variety of cannabis products. They operate in a competitive market, leveraging partnerships to expand their product …
What does Indiva Limited do?
Indiva Limited is a Canadian cannabis company focused on the production, processing, and sale of cannabis and cannabis-related products. They offer a diverse range of products, including pre-rolls, flower, capsules, and edibles, marketed under the INDIVA and Artisan Batch brands. Indiva also provides production and manufacturing services to other entities in the cannabis industry.
What are the main risks for NDVAF?
Indiva Limited faces several risks inherent to the cannabis industry and its specific business operations. Intense competition in the Canadian cannabis market could pressure pricing and market share. Fluctuations in cannabis prices and potential supply chain disruptions could impact profitability. The company's negative profit margin indicates financial challenges.
What are the key factors to evaluate for NDVAF?
Indiva Limited (NDVAF) holds an AI score of 42/100 (low). Indiva Limited operates in the evolving Canadian cannabis market, presenting both opportunities and risks for investors. Not financial advice.
How frequently does NDVAF data refresh on this page?
NDVAF's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven NDVAF's recent stock price performance?
Indiva Limited (NDVAF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product portfolio through partnerships. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider NDVAF overvalued or undervalued right now?
Indiva Limited (NDVAF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research NDVAF before investing?
Before investing in Indiva Limited (NDVAF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding NDVAF to a portfolio?
Key strength of Indiva Limited (NDVAF): Diverse product portfolio through partnerships. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data available.
- AI analysis pending.